{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:07:43Z","timestamp":1789614463643,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00431-021-04159-z","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T01:02:43Z","timestamp":1624928563000},"page":"2669-2676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Supraventricular tachycardias in neonates and infants: factors associated with fatal or near-fatal outcome"],"prefix":"10.1007","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7012-6133","authenticated-orcid":false,"given":"L\u00e1szl\u00f3","family":"K\u00f6rnyei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"R\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Ferenci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Kardos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"issue":"1","key":"4159_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0002-8703(96)90052-6","volume":"131","author":"SN Weindling","year":"1996","unstructured":"Weindling SN, Saul JP, Walsh EP (1996) Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. Am Heart J 131(1):66\u201372","journal-title":"Am Heart J"},{"issue":"8","key":"4159_CR2","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/j.1651-2227.2008.00823.x","volume":"97","author":"T Gilljam","year":"2008","unstructured":"Gilljam T, Jaeggi E, Gow RM (2008) Neonatal supraventricular tachycardia: outcomes over a 27-year period at a single institution. Acta Paediatr 97(8):1035\u20131039","journal-title":"Acta Paediatr"},{"issue":"7","key":"4159_CR3","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/j.1540-8159.2011.03073.x","volume":"34","author":"JC Salerno","year":"2011","unstructured":"Salerno JC, Garrison MM, Larison C, Seslar SP (2011) Case fatality in children with supraventricular tachycardia in the United States. Pacing Clin Electrophysiol 34(7):832\u2013836","journal-title":"Pacing Clin Electrophysiol"},{"issue":"12","key":"4159_CR4","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJM199103213241201","volume":"324","author":"DS Echt","year":"1991","unstructured":"Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Huther ML, Richardson DW (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324(12):781\u2013788","journal-title":"N Engl J Med"},{"issue":"9","key":"4159_CR5","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1093\/europace\/eut082","volume":"15","author":"J Brugada","year":"2013","unstructured":"Brugada J, Blom N, Sarquella-Brugada G, Blomstrom-Lundqvist C, Deanfield J, Janousek J, Abrams D, Bauersfeld U, Brugada R, Drago F, de Groot N, Happonen JM, Hebe J, Yen Ho S, Marijon E, Paul T, Pfammatter JP, Rosenthal E (2013) Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace. 15(9):1337\u20131382","journal-title":"Europace."},{"issue":"3","key":"4159_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0002-8703(94)90634-3","volume":"128","author":"NZ Kerin","year":"1994","unstructured":"Kerin NZ, Somberg J (1994) Proarrhythmia: definition, risk factors, causes, treatment, and controversies. Am Heart J 128(3):575\u2013585","journal-title":"Am Heart J"},{"key":"4159_CR7","unstructured":"Homoud. Antiarrhythmic drugs and miscellaneous topics: Tufts OpenCourseWare; 2007"},{"issue":"5","key":"4159_CR8","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1161\/01.CIR.65.5.886","volume":"65","author":"V Velebit","year":"1982","unstructured":"Velebit V, Podrid P, Lown B, Cohen BH, Graboys TB (1982) Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation. 65(5):886\u2013894","journal-title":"Circulation."},{"issue":"14","key":"4159_CR9","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1161\/CIRCULATIONAHA.109.894725","volume":"122","author":"EK Heist","year":"2010","unstructured":"Heist EK, Ruskin JN (2010) Drug-induced arrhythmia. Circulation. 122(14):1426\u20131435","journal-title":"Circulation."},{"issue":"2","key":"4159_CR10","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00246-012-0474-6","volume":"34","author":"SP Seslar","year":"2013","unstructured":"Seslar SP, Garrison MM, Larison C, Salerno JC (2013) A multi-institutional analysis of inpatient treatment for supraventricular tachycardia in newborns and infants. Pediatr Cardiol 34(2):408\u2013414","journal-title":"Pediatr Cardiol"},{"issue":"6","key":"4159_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.earlhumdev.2015.04.001","volume":"91","author":"PY Chu","year":"2015","unstructured":"Chu PY, Hill KD, Clark RH, Smith PB, Hornik CP (2015) Treatment of supraventricular tachycardia in infants: analysis of a large multicenter database. Early Hum Dev 91(6):345\u2013350","journal-title":"Early Hum Dev"},{"issue":"5","key":"4159_CR12","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/jce.14406","volume":"31","author":"ET O\u2019Leary","year":"2020","unstructured":"O\u2019Leary ET, Alexander ME, Bezzerides VJ, Drogosz M, Economy KE, Friedman KG et al (2020) Low mortality in fetal supraventricular tachycardia: outcomes in a 30-year single-institution experience. J Cardiovasc Electrophysiol 31(5):1105\u20131113","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"4159_CR13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/0735-1097(91)90586-X","volume":"18","author":"FA Fish","year":"1991","unstructured":"Fish FA, Gillette PC, Benson DW Jr (1991) Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. J Am Coll Cardiol 18(2):356\u2013365","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"4159_CR14","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.jacc.2005.06.061","volume":"46","author":"S L\u00e4er","year":"2005","unstructured":"L\u00e4er S, Elshoff JP, Meibohm B, Weil J, Mir TS, Zhang W, Hulpke-Wette M (2005) Development of a safe and effective pediatric dosing regimen for sotalol based on population pharmacokinetics and pharmacodynamics in children with supraventricular tachycardia. J Am Coll Cardiol 46(7):1322\u20131330","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"4159_CR15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s00246-014-0978-3","volume":"36","author":"BS Moffett","year":"2015","unstructured":"Moffett BS, Valdes SO, Lupo PJ, dela Uz C, Miyake C, Krenek M et al (2015) Flecainide use in children with cardiomyopathy or structural heart disease. Pediatr Cardiol 36(1):146\u2013150","journal-title":"Pediatr Cardiol"},{"issue":"5","key":"4159_CR16","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1161\/CIRCEP.112.972620","volume":"5","author":"S Sanatani","year":"2012","unstructured":"Sanatani S, Potts JE, Reed JH, Saul JP, Stephenson EA, Gibbs KA, Anderson CC, Mackie AS, Ro PS, Tisma-Dupanovic S, Kanter RJ, Batra AS, Fournier A, Blaufox AD, Singh HR, Ross BA, Wong KK, Bar-Cohen Y, McCrindle BW, Etheridge SP (2012) The study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants. Circ Arrhythm Electrophysiol 5(5):984\u2013991","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"8","key":"4159_CR17","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s00246-017-1707-5","volume":"38","author":"T Cunningham","year":"2017","unstructured":"Cunningham T, Uzun O, Morris R, Franciosi S, Wong A, Jeremiasen I, Sherwin E, Sanatani S (2017) The safety and effectiveness of flecainide in children in the current era. Pediatr Cardiol 38(8):1633\u20131638","journal-title":"Pediatr Cardiol"},{"issue":"22","key":"4159_CR18","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1161\/CIRCULATIONAHA.105.534149","volume":"112","author":"JP Saul","year":"2005","unstructured":"Saul JP, Scott WA, Brown S, Marantz P, Acevedo V, Etheridge SP, Perry JC, Triedman JK, Burriss SW, Cargo P, Graepel J, Koskelo EK, Wang R, Intravenous Amiodarone Pediatric Investigators (2005) Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial. Circulation. 112(22):3470\u20133477","journal-title":"Circulation."},{"issue":"15","key":"4159_CR19","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/0002-9149(87)90935-0","volume":"59","author":"A Garson","year":"1987","unstructured":"Garson A, Moak JP, Smith RT, Norton JB (1987) Usefulness of intravenous propafenone for control of postoperative junctional ectopic tachycardia. Am J Cardiol 59(15):1422\u20131424","journal-title":"Am J Cardiol"},{"issue":"12","key":"4159_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002949","volume":"95","author":"WT Zeng","year":"2016","unstructured":"Zeng WT, Liu ZH, Li ZY, Zhang M, Cheng YJ (2016) Digoxin use and adverse outcomes in patients with atrial fibrillation. Medicine (Baltimore) 95(12):e2949","journal-title":"Medicine (Baltimore)"},{"key":"4159_CR21","doi-asserted-by":"crossref","unstructured":"Asirvatham SJ, editor. Mayo Clinic Electrophysiology Manual: Oxford University Press; 2014.","DOI":"10.1093\/med\/9780199941193.001.0001"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-021-04159-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-021-04159-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-021-04159-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T13:11:12Z","timestamp":1626441072000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-021-04159-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["4159"],"URL":"https:\/\/doi.org\/10.1007\/s00431-021-04159-z","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]},"assertion":[{"value":"17 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by the authors. This study was approved by the Medical Research Council (IV\/4718-2\/2020\/EKU), and informed consent was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"N\/A","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}